HEMOLYSATE-MEDIATED PLATELET AGGREGATION: AN ADDITIONAL RISK MECHANISM CONTRIBUTING TO THROMBOSIS OF CONTINUOUS FLOW VENTRICULAR ASSIST DEVICES

Despite the clinical success and growth in the utilization of continuous flow ventricular assist devices (cfVADs) for the treatment of advanced heart failure, hemolysis and thrombosis remain major limitations. Inadequate and/or ineffective anticoagulation regimens, combined with high pump speed and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Perfusion
Autori principali: Tran, Phat L., Pietropaolo, Maria-Grazia, Valerio, Lorenzo, Brengle, William, Wong, Raymond K., Kazui, Toshinobu, Khalpey, Zain I., Redaelli, Alberto, Sheriff, Jawaad, Bluestein, Danny, Slepian, Marvin J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4874907/
https://ncbi.nlm.nih.gov/pubmed/26590166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0267659115615206
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi